QWM
REGN icon

Quaker Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quaker Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$1.27K – 1520
2025
Q1 		$1.27K Buy
+2
New +$1.38K ﹤0.01% 455

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return

Quaker Wealth Management's REGN Position: Q2 2026 in Review

Quaker Wealth Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 2 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

Quaker Wealth Management first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.55K in Q1 2026. 415 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Quaker Wealth Management held 2 shares of Regeneron Pharmaceuticals worth $1.25K as of Q2 2026.
  • Quaker Wealth Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #533 holding.
  • Quaker Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's Regeneron Pharmaceuticals position peaked at $1.55K in Q1 2026.
  • 415 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.